Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

ViiV Healthcare UK Ltd
Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 09/05/2012
PIL Epivir Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
  • Change to manufacturer contact details
Updated on 25/11/2010 and displayed until 09/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 23/09/2010 and displayed until 25/11/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 15/06/2010 and displayed until 23/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 05/01/2010 and displayed until 15/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/12/2009 and displayed until 05/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 11/09/2008 and displayed until 09/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 22/03/2007 and displayed until 11/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/09/2006 and displayed until 22/03/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 22/09/2006 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 18/04/2005 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/07/2004 and displayed until 18/04/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 26/03/2004 and displayed until 01/07/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 23/12/2002 and displayed until 26/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 22/03/2001 and displayed until 23/12/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/01/2001 and displayed until 22/03/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  lamivudine